Retatrutide
Triple receptor agonist targeting GLP-1, GIP, and glucagon receptors. Phase 3 trials recorded up to 24.2% body weight reduction — the highest of any compound in its class.
Studied Benefits
- Triple-receptor agonism
- Appetite suppression
- Fat mass reduction
- Metabolic regulation
Research Use Only
This compound is intended for laboratory and research purposes only. It is not approved for human consumption and is not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare professional.
Independently Reviewed
We only list vendors that publish third-party, batch-specific COAs.
Apollo Peptide Sciences
Buy Direct from Apollo Peptide Sciences →Behemoth Labz
Buy Direct from Behemoth Labz →Ignite Peptides
Buy Direct from Ignite Peptides →Affiliate disclosure: links above are affiliate partnerships. We may earn a commission at no cost to you.
Related in Weight Management
Semaglutide (GLP-1)
GLP-1 receptor agonist widely studied for appetite regulation, blood sugar control, and body composition.
View product →
AOD-9604
Synthetic fragment of human growth hormone (hGH 176-191) studied for its role in fat metabolism and lipolysis without affecting blood sugar or IGF-1 levels.
View product →
Make this protocol yours
The Engine reads your biometrics and personalizes dosing, timing, and stacking — free at auraprotocols.com.
Try the Engine →